Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunotherapies using enhanced iPSC derived effector cells

Immunotherapies using enhanced iPSC derived effector cells

US Patent 12435123 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for immune cell modulation in adoptive immunotherapies2025
Compositions and methods for immune cell modulation in adoptive immunotherapies2025
Cell culture platform for single cell sorting and enhanced reprogramming of iPSC2025
Methods and compositions for inducing hematopoietic cell differentiation2025
Methods and compositions for inducing hematopoietic cell differentiation2025
Enhanced immune effector cells and use thereof2025
Enhanced immune effector cells and use thereof2025
Enhanced immune effector cells and use thereof2025
Methods and compositions for inducing hematopoietic cell differentiation2025
Platform for the induction and maintenance of ground state pluripotency2025
Compositions and methods for immune cell modulation in adoptive immunotherapies2025
Compositions and methods for immune cell modulation in adoptive immunotherapies2025